About the Journal
Medical Times, a leading, peer-reviewed scholarly journal, is committed to advancing medical science, focusing on reproductive health. The journal's dedication is evident in its mission to address persistent and emerging challenges in this dynamic field, providing an authoritative platform for disseminating innovative research, clinical advancements, and critical analyses.
The journal serves as an essential resource for clinicians, researchers, educators, and policymakers, offering a comprehensive range of topics central to reproductive health, including, but not limited to, Reproductive endocrinology, Assisted reproductive technologies (ART), Gynecology and obstetrics, Male and female infertility, and Reproductive genetics.
Each issue of Medical Times is rigorously curated to ensure the publication of content that is not only scientifically sound but also clinically relevant and ethically grounded. The journal upholds a stringent peer-review process to guarantee that only methodologically rigorous and high-impact studies are disseminated.
Current Issue
The journal issue focuses on advancements in reproductive medicine, particularly in assisted reproductive technologies (ART), in vitro fertilization (IVF), and related areas of fertility and reproductive health. It brings together an array of research studies, clinical reviews, and innovative approaches from international experts in the field, with a strong emphasis on both male and female fertility challenges.
Key topics include the use of artificial intelligence (AI) in IVF, genetic polymorphisms affecting pregnancy outcomes, and the impact of conditions such as polycystic ovary syndrome (PCOS) and endometriosis on fertility. Several articles explore innovative therapeutic strategies, such as metabolic treatments for male infertility, regenerative therapies for endometrial health, and stem cell therapy in reproductive medicine.
Overall, the journal offers comprehensive insights into the latest scientific advances and clinical practices aimed at improving fertility outcomes, addressing recurrent implantation failure, and optimizing IVF techniques to tackle both common and rare fertility challenges faced by patients.